We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
Cap. Flow
-$2.02B
Cap. Flow %
-2.45%
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 26.12%
2 Consumer Discretionary 15.99%
3 Communication Services 13.72%
4 Healthcare 12.84%
5 Industrials 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTD icon
51
Mettler-Toledo International
MTD
$28.6B
$194M 0.23%
139,752
-2,236
-2% -$2.88M
TXN icon
52
Texas Instruments
TXN
$261B
$193M 0.23%
1,002,604
-37,545
-4% -$7.04M
TSM icon
53
TSMC
TSM
$2.18T
$175M 0.21%
1,453,104
-977
-0.1% -$114K
MELI icon
54
Mercado Libre
MELI
$92.3B
$170M 0.21%
109,343
+3,389
+3% +$4.98M
VRSN icon
55
VeriSign
VRSN
$26.6B
$168M 0.2%
739,175
-138,469
-16% -$30.1M
FTCH
56
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$164M 0.2%
3,265,724
+785,456
+32% +$37.3M
TMUS icon
57
T-Mobile US
TMUS
$190B
$163M 0.2%
1,128,504
+1,128,419
+1,327,552% +$156M
ALNY icon
58
Alnylam Pharmaceuticals
ALNY
$29.3B
$160M 0.19%
+946,065
New +$139M
DBX icon
59
Dropbox
DBX
$8.12B
$160M 0.19%
5,274,097
-2,383,505
-31% -$65.1M
CRSP icon
60
CRISPR Therapeutics
CRSP
$5.17B
$147M 0.18%
+908,652
New +$111M
SITE icon
61
SiteOne Landscape Supply
SITE
$4.53B
$139M 0.17%
821,576
-68,838
-8% -$12M
WMS icon
62
Advanced Drainage Systems
WMS
$10.9B
$138M 0.17%
1,184,515
-4,491
-0.4% -$499K
FRPT icon
63
Freshpet
FRPT
$3.22B
$132M 0.16%
808,441
-124,523
-13% -$21.2M
UAA icon
64
Under Armour
UAA
$2.6B
$126M 0.15%
5,946,405
-361,832
-6% -$8.07M
BMY icon
65
Bristol-Myers Squibb
BMY
$132B
$125M 0.15%
1,876,576
-3,409,763
-65% -$222M
PRAH
66
DELISTED
PRA Health Sciences, Inc.
PRAH
$116M 0.14%
703,970
-1,373
-0.2% -$229K
CPRT icon
67
Copart
CPRT
$27.5B
$116M 0.14%
3,528,376
-374,568
-10% -$11.6M
NOC icon
68
Northrop Grumman
NOC
$81.2B
$110M 0.13%
303,360
-99,814
-25% -$35.9M
KRNT icon
69
Kornit Digital
KRNT
$791M
$108M 0.13%
868,646
+96,246
+12% +$10.2M
RPD icon
70
Rapid7
RPD
$773M
$103M 0.13%
1,093,427
+26,270
+2% +$2.21M
GS icon
71
Goldman Sachs
GS
$303B
$103M 0.12%
270,666
-2,975
-1% -$1.06M
FOXF icon
72
Fox Factory Holding Corp
FOXF
$886M
$100M 0.12%
642,820
-155,303
-19% -$23.1M
LHCG
73
DELISTED
LHC Group LLC
LHCG
$99.8M 0.12%
498,140
-558
-0.1% -$112K
SLAB icon
74
Silicon Laboratories
SLAB
$7.23B
$97M 0.12%
633,268
+709
+0.1% +$99.1K
QTWO icon
75
Q2 Holdings
QTWO
$3.92B
$94.7M 0.11%
923,513
+1,315
+0.1% +$132K

Similar funds

Loomis, Sayles & Company's Q2 2021 Portfolio in Review

As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
  • Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
  • Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
  • Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
  • Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
  • Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
  • Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.